Jeff Macdonald is Director, Corporate Communications at Acorda Therapeutics, a biotechnology company focused on developing treatments for neurological diseases.  He is responsible for corporate, financial and brand communications, including leading public relations activities for Acorda’s first major therapy approved in 2010.  Jeff also provides strategic counsel and day-to-day support on the company’s investor relations initiatives. 

Prior to joining Acorda, Jeff worked at Bristol-Myers Squibb in both brand and corporate communications roles.  Previously, he held positions at several large public relations agencies in Washington, DC and New York.

Jeff received his BA in English and journalism from Washington and Lee University.